Pharmacy Benefit Manager (“PBM”) arrangements have long relied on rebates with limited transparency into true drug costs. Recent regulatory and ...
Add Yahoo as a preferred source to see more of our stories on Google. Lobbyists and task force members listen to presentations at an Oct. 8, 2024 meeting of the Health Care Cost Oversight Task Force ...
Tensions between the Federal Trade Commission (FTC) and pharmacy benefit managers (PBMs) continue to mount, bringing PBM practices and calls for reform back into the spotlight. On September 17, 2024, ...
The American Medical Association (AMA) provided ammunition today to regulators, policymakers and legislators concerned about just what role pharmacy benefit managers play in the drug supply chain. An ...
Federal pharmacy benefit manager transparency reforms must contend with concentrated pharmaceutical markets that lack competitive conditions. Learnings from transparency will shape future drug pricing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results